Amneal Pharmaceuticals (AMRX) Reports In-Line Q3 EPS, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. DOX
7. ON
8. HNGE
9. INSP
10. SPY

Go back to Amneal Pharmaceuticals (AMRX) Reports In-Line Q3 EPS, Revenues Miss

Amneal Announces Solid Third Quarter 2018 Financial Results

November 7, 2018 6:55 AM EST

BRIDGEWATER, N.J., Nov. 7, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the quarter ended September 30, 2018.

"The third quarter was defined by solid financial performance and strategic accomplishments as we advanced the integration of Impax and Amneal, completed two strategic partnerships that strengthen our portfolio and launched 11... More